These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36124848)

  • 21. Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.
    Muller-Serieys C; Saleh Mghir A; Massias L; Fantin B
    Antimicrob Agents Chemother; 2009 May; 53(5):2145-8. PubMed ID: 19273687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.
    Gomes F; Teixeira P; Ceri H; Oliveira R
    Indian J Med Res; 2012 Apr; 135(4):542-7. PubMed ID: 22664505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates.
    Mandell JB; Orr S; Koch J; Nourie B; Ma D; Bonar DD; Shah N; Urish KL
    J Orthop Res; 2019 Jul; 37(7):1604-1609. PubMed ID: 30919513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
    Baldoni D; Haschke M; Rajacic Z; Zimmerli W; Trampuz A
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrvinium pamoate potentiates levofloxacin against levofloxacin-resistant
    Kaul G; Karale UB; Akhir A; Shukla M; Saxena D; Rode HB; Chopra S
    Future Microbiol; 2022 Dec; 17():1475-1486. PubMed ID: 36314364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus.
    Jacob B; Makarewicz O; Hartung A; Brodt S; Roehner E; Matziolis G
    Sci Rep; 2021 Dec; 11(1):23425. PubMed ID: 34873186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampicin fails to eradicate mature biofilm formed by methicillin-resistant Staphylococcus aureus.
    Reiter KC; Sambrano GE; Villa B; Paim TG; de Oliveira CF; d'Azevedo PA
    Rev Soc Bras Med Trop; 2012; 45(4):471-4. PubMed ID: 22930045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the effect of rifampicin resistance and risk factors on recovery rates after DAIR procedure in patients with prosthetic joint infection.
    Krizsán G; Sallai I; Veres DS; Prinz G; Kovács M; Skaliczki G
    J Orthop Surg Res; 2023 Aug; 18(1):611. PubMed ID: 37605214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
    Yan Q; Karau MJ; Raval YS; Patel R
    Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin.
    Rahman M; Kim S; Kim SM; Seol SY; Kim J
    Biofouling; 2011 Nov; 27(10):1087-93. PubMed ID: 22050201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study.
    Lesens O; Ferry T; Forestier E; Botelho-Nevers E; Pavese P; Piet E; Pereira B; Montbarbon E; Boyer B; Lustig S; Descamps S;
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1949-1956. PubMed ID: 30083889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an
    Morrisette T; Stamper KC; Lev KL; Kebriaei R; Holger DJ; Abdul-Mutakabbir JC; Kunz Coyne AJ; Rybak MJ
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0131722. PubMed ID: 37222591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.
    Revest M; Jacqueline C; Boudjemaa R; Caillon J; Le Mabecque V; Breteche A; Steenkeste K; Tattevin P; Potel G; Michelet C; Fontaine-Aupart MP; Boutoille D
    J Antimicrob Chemother; 2016 May; 71(5):1291-9. PubMed ID: 26851611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays.
    Abbanat D; Shang W; Amsler K; Santoro C; Baum E; Crespo-Carbone S; Lynch AS
    Int J Antimicrob Agents; 2014 Jan; 43(1):32-9. PubMed ID: 24252780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis.
    Yusuf E; Bramer W; Anas AA
    Int J Antimicrob Agents; 2024 Jan; 63(1):107015. PubMed ID: 37875179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections.
    Thill P; Robineau O; Roosen G; Patoz P; Gachet B; Lafon-Desmurs B; Tetart M; Nadji S; Senneville E; Blondiaux N
    J Antimicrob Chemother; 2022 Mar; 77(4):1036-1040. PubMed ID: 35028671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.